CNS tumor
Showing 51 - 75 of >10,000
Relapsed Solid Tumor, Refractory Solid Tumor, Relapsed CNS Tumor Trial in United States (cemiplimab (monotherapy), cemiplimab
Recruiting
- Relapsed Solid Tumor
- +5 more
- cemiplimab (monotherapy)
- +3 more
-
Los Angeles, California
- +19 more
Jan 27, 2022
Ewing Sarcoma, Neuroblastoma, Rhabdomyosarcoma Trial in Milwaukee (Allogeneic HCT, Donor NK Cell Infusion)
Active, not recruiting
- Ewing Sarcoma
- +4 more
- Allogeneic HCT
- Donor NK Cell Infusion
-
Milwaukee, Wisconsin
- +1 more
Apr 5, 2022
Glioblastoma Multiforme, Meningioma Trial in Phoenix (Ribociclib)
Recruiting
- Glioblastoma Multiforme
- Meningioma
-
Phoenix, ArizonaBarrow Brain and Spine
Oct 7, 2021
Germ Cell Tumor, CNS Germ Cell Tumor Trial in Boston (Proton Beam radiation)
Active, not recruiting
- Germ Cell Tumor
- Central Nervous System Germ Cell Tumor
- Proton Beam radiation
-
Boston, Massachusetts
- +1 more
Jan 3, 2021
High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))
Recruiting
- High Grade Glioma
- +12 more
- LUTATHERA® (Lutetium Lu 177 dotatate)
-
Aurora, Colorado
- +8 more
Jan 16, 2023
Pediatric Solid Tumor, Refractory Tumor, Recurrent Tumor Trial in United States (Ramucirumab)
Completed
- Pediatric Solid Tumor
- +3 more
-
Birmingham, Alabama
- +20 more
Jul 23, 2021
Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)
Recruiting
- Adenocarcinoma
- +75 more
- Biomarker Testing (L)
- +2 more
-
Idaho Falls, Idaho
- +1 more
Oct 18, 2022
Glioblastoma, Astrocytoma, Pineoblastoma Trial in Chicago (Stem Cell Transplant)
Completed
- Glioblastoma
- +4 more
- Stem Cell Transplant
-
Chicago, IllinoisChildren's Memorial Hospital
Aug 3, 2020
CNS Tumors, Pediatric Cancer, GEN1 Gene Mutation Trial in Brno, Prague (FoundationOneHeme)
Recruiting
- Central Nervous System Neoplasms
- +3 more
- FoundationOneHeme
-
Brno, Czechia
- +1 more
Apr 23, 2021
Rare Embryonal Tumors of Central Nervous System: International
Not yet recruiting
- Embryonal Tumor
-
Yerevan, ArmeniaHematology Center named after prof. R. Yeolyan
Jan 25, 2023
Somatic Mosaicism in Twins Discordant for Childhood Cancer
Not yet recruiting
- Pediatric Central Nervous System Tumor
- +3 more
- Biospecimen collection
- Questionnaire Administration
- (no location specified)
Sep 19, 2023
Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma Trial in Worldwide (Oral repotrectinib (TPX-0005))
Recruiting
- Locally Advanced Solid Tumors
- +3 more
- Oral repotrectinib (TPX-0005)
-
Los Angeles, California
- +27 more
Aug 9, 2022
Rare CNS Tumors Outcomes &Risk
Recruiting
- High Grade Meningioma
- +4 more
-
Bethesda, MarylandNational Cancer Institute (NCI)
Jul 6, 2022
Tissue Collection for Drug Screening and Bioanalysis
Recruiting
- Pediatric Central Nervous System Tumor
- Central Nervous System Tumor
-
New York, New YorkWeill Cornell Medicine
Nov 28, 2022
Non-hodgkin Lymphoma, B Cell Trial in Switzerland (ctDNA detection)
Not yet recruiting
- Non-hodgkin Lymphoma, B Cell
- ctDNA detection
-
Aarau, Switzerland
- +12 more
Oct 18, 2023
Radiation Therapy in Pediatric Central Nervous System Tumors
Completed
- Diffuse Intrinsic Pontine Glioma
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Childhood Brain Tumor Trial in Germany
Active, not recruiting
- Childhood Brain Tumor
-
Aachen, Germany
- +55 more
Apr 11, 2022
CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric
Recruiting
- Central Nervous System Tumor
- +10 more
- SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
-
Seattle, WashingtonSeattle Children's Hospital
Dec 14, 2022
Medical Marijuana in Pediatric Central Nervous System Tumor
Active, not recruiting
- Central Nervous System Tumor
- +2 more
-
Aurora, ColoradoChilsdren's Hospital Colorado
Oct 14, 2022
PET-CT Imaging in Relapsed/Refractory Acute Leukemias
Not yet recruiting
- B Cell
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 4, 2023
CNS Germ Cell Tumor Trial in United States (Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx).)
Completed
- CNS Germ Cell Tumor
- Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx).
-
Phoenix, Arizona
- +4 more
Jan 5, 2021
Non Small Cell Lung Cancer, CNS Progression Trial in Aurora (Temozolomide plus Osimertinib, Temozolomide plus Lorlatinib)
Active, not recruiting
- Non Small Cell Lung Cancer
- CNS Progression
- Temozolomide plus Osimertinib
- Temozolomide plus Lorlatinib
-
Aurora, ColoradoUniversity of Colorado Hospital
May 12, 2022